Adamant Biomedical Investments AG

Business address
Freischuetzgasse 3, Zurich, Switzerland, 8004
Top securities (13F)
CELG, BIIB, GILD, AMGN, B108PS, UNH, MYL, CTRX, ALXN, MDT, VRTX, REGN, MCK, EARS, MNKKQ, ABT, AGN, ILMN, ACAD, and MDVN
State of incorporation
Switzerland
Fiscal year end
31 December
Adamant Biomedical Investments AG has filed 14 SEC EDGAR filings since 14 Feb 2012

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
13F-HR Open Document Open Filing 13 Feb 2015 31 Dec 2014 028-14829
SC 13G Open Document Open Filing SCHEDULE 13G 13 Feb 2015
13F-HR Open Document Open Filing 14 Nov 2014 30 Sep 2014 028-14829
13F-NT Open Document Open Filing 07 Aug 2014 30 Jun 2014 028-14829
13F-NT Open Document Open Filing 29 Apr 2014 31 Mar 2014 028-14829
13F-NT Open Document Open Filing 03 Feb 2014 31 Dec 2013 028-14829